The Animal Facility is a separate building consisting of four floors and 27 rooms, primarily for holding rodents. All rooms are humidity and temperature controlled. Air flow is balanced to reduce airborne contamination from animals and personnel. Automatic lighting is provided in each animal room. A single corridor system is used on the second floor and clean/dirty corridor systems are used on the third and fourth floors. All supplies are sterilized before being placed in the clean corridor. The first floor is mainly a service area housing the cage washers, a cold room, an autoclave, offices, quarantine room, and supply storage. The third floor contains SCID/RAG-1, CB-17 SCID, and C3H SCID breeding rooms. Micro-injection and procedural laboratories are also located on this floor. The fourth floor is used for housing experimental animals and contains two common-use rooms, two containment rooms, and one room containing isolators. The facility contains the equipment required to maintain and support the resource. The Animal Facility offers centralized ordering of all animals, examination of animals upon arrival, routine monitoring of animals for health status, collection of blood samples for viral screening, collection of organs for histopathology, clipping of nails and teeth, grooming of coats and furs, and administration of medication. Special rooms are provided for containment, athymic nude mice, SCID mice, and quarantine. These special rooms have separate operating procedures, isolation compartments with individual exhaust systems, and a biosafety hood. Health monitoring is accomplished by the use of sentinel animals, testing of animals while in quarantine, and the use of an approved vendor list. Security of the facility is maintained by limiting access to authorized personnel only. During normal working hours, all individuals entering the Animal Facility must pass the facility office. Individuals not recognized by the supervisory staff are stopped and asked for proper identification. The animal health surveillance program includes serological and bacteriological testing by independent diagnostic laboratories. Samples are taken from rodents on a rotating basis for common murine viruses, bacteria, and parasites. Endo- and ecto-parasite testing is completed either by a veterinary technician or the consulting veterinarian. The veterinarian is responsible for animal health and for reviewing the husbandry and management of the facility. Coverage for emergencies and for unusual animal health difficulties is provided by two additional veterinarians on-call. The institution encourages and supports American Association for Laboratory Animal Science (AALAS) certification for the animal technicians and managers. There are two committees involved in animal care and use oversight. The Institutional Animal Care and Use Committee (IACUC) meets once a month and is responsible for the review and approval of all animal use protocols and the duties outlined in the Animal Welfare Regulations. This committee is responsible for evaluating all aspects of animal care and use including protocol review. The Animal Facility Advisory Committee (AFAC) meets monthly to review policy implementation and to discuss problems and future needs. The Facility Director, veterinarian, and manager attend regularly scheduled weekly meetings to discuss problems and inspect the facility.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA010815-34S2
Application #
6595930
Study Section
Project Start
2002-03-01
Project End
2003-02-28
Budget Start
Budget End
Support Year
34
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Wistar Institute
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Hu, Xiaowen; Sood, Anil K; Dang, Chi V et al. (2018) The role of long noncoding RNAs in cancer: the dark matter matters. Curr Opin Genet Dev 48:8-15
Saglam, Ozlen; Conejo-Garcia, Jose (2018) PD-1/PD-L1 immune checkpoint inhibitors in advanced cervical cancer. Integr Cancer Sci Ther 5:
Liu, Shujing; Zhang, Gao; Guo, Jianping et al. (2018) Loss of Phd2 cooperates with BRAFV600E to drive melanomagenesis. Nat Commun 9:5426
Duperret, Elizabeth K; Trautz, Aspen; Stoltz, Regina et al. (2018) Synthetic DNA-Encoded Monoclonal Antibody Delivery of Anti-CTLA-4 Antibodies Induces Tumor Shrinkage In Vivo. Cancer Res 78:6363-6370
Papasavvas, Emmanouil; Lada, Steven M; Joseph, Jocelin et al. (2018) Analytical ART interruption does not irreversibly change pre-interruption levels of cellular HIV. AIDS :
Kugel 3rd, Curtis H; Douglass, Stephen M; Webster, Marie R et al. (2018) Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell Populations. Clin Cancer Res 24:5347-5356
Reyes-Uribe, Patricia; Adrianzen-Ruesta, Maria Paz; Deng, Zhong et al. (2018) Exploiting TERT dependency as a therapeutic strategy for NRAS-mutant melanoma. Oncogene 37:4058-4072
Bhattacharjee, Souvik; Coppens, Isabelle; Mbengue, Alassane et al. (2018) Remodeling of the malaria parasite and host human red cell by vesicle amplification that induces artemisinin resistance. Blood 131:1234-1247
Fukumoto, Takeshi; Park, Pyoung Hwa; Wu, Shuai et al. (2018) Repurposing Pan-HDAC Inhibitors for ARID1A-Mutated Ovarian Cancer. Cell Rep 22:3393-3400
Thangavel, Chellappagounder; Boopathi, Ettickan; Liu, Yi et al. (2018) Therapeutic Challenge with a CDK 4/6 Inhibitor Induces an RB-Dependent SMAC-Mediated Apoptotic Response in Non-Small Cell Lung Cancer. Clin Cancer Res 24:1402-1414

Showing the most recent 10 out of 741 publications